Xiaofeng Chen
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Co-authors
- Huijun Zhang (4 shared papers)Dayu Huang (5 shared papers)Mingchuan Zhao (4 shared papers)Qinyun Ma (6 shared papers)Jiucun Wang (3 shared papers)Shicheng Guo (3 shared papers)Hongtao Zhang (3 shared papers)Haibing Wang (3 shared papers)
- Journals
- Oncotarget (3 papers)International Immunopharmacology (3 papers)Cancer Science (2 papers)Frontiers in Pharmacology (2 papers)Neuroreport (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Xiaofeng Chen
60 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 212
- Oncology 342
- Immunology 161
- Molecular Biology 485
- Pulmonary and Respiratory Medicine 163
Countries citing papers authored by Xiaofeng Chen
This map shows the geographic impact of Xiaofeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Chen more than expected).
Fields of papers citing papers by Xiaofeng Chen
This network shows the impact of papers produced by Xiaofeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Chen. The network helps show where Xiaofeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 130 | |
| 2 | 2011 | 114 | |
| 3 | 2011 | 71 | |
| 4 | 2015 | 59 | |
| 5 | 2021 | 58 | |
| 6 | 2014 | 56 | |
| 7 | 2021 | 51 | |
| 8 | 2016 | 50 | |
| 9 | 2016 | 43 | |
| 10 | 2020 | 40 | |
| 11 | 2017 | 40 | |
| 12 | 2022 | 37 | |
| 13 | 2022 | 32 | |
| 14 | 2012 | 30 | |
| 15 | 2011 | 29 | |
| 16 | 2022 | 27 | |
| 17 | 2021 | 27 | |
| 18 | 2019 | 23 | |
| 19 | 2017 | 21 | |
| 20 | 2020 | 21 |
About Xiaofeng Chen
Xiaofeng Chen is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 63 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Cancer Cells and Metastasis (6 papers), Genital Health and Disease (4 papers), Ferroptosis and cancer prognosis (4 papers), Esophageal Cancer Research and Treatment (4 papers), Immune cells in cancer (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Cancer Research (212 citations), Oncology (342 citations), Immunology (161 citations), Molecular Biology (485 citations) and Pulmonary and Respiratory Medicine (163 citations). Xiaofeng Chen has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Huijun Zhang, Dayu Huang, Mingchuan Zhao, Qinyun Ma, Jiucun Wang, Shicheng Guo, Hongtao Zhang, Haibing Wang, Heyong Wang and Hui Zhang. Their work appears in journals such as Oncotarget, International Immunopharmacology, Cancer Science, Frontiers in Pharmacology and Neuroreport.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.